![Dominik Höchli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominik Höchli
Direktor/Vorstandsmitglied bei
MOLECULAR PARTNERS AG
Vermögen: 20 021 $ am 31.05.2026
Profil
Currently, Dominik Höchli is an Independent Non-Executive Director at Molecular Partners AG since 2021 and a Director at Abivax SA starting in 2025.
Formerly, Dr. Höchli was Co-Managing Director at Catapult Therapeutics BV from 2021 to 2025 and Vice President & Head-Global Medical Affairs at AbbVie AG.
Education includes a doctorate from the University of Bern.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 4’982 ( 0.01% ) | 20 021 $ | 31.05.2026 |
Aktive Positionen von Dominik Höchli
| Unternehmen | Position | Beginn |
|---|---|---|
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 21.04.2021 |
| ABIVAX | Direktor/Vorstandsmitglied | 22.04.2025 |
Ehemalige bekannte Positionen von Dominik Höchli
| Unternehmen | Position | Ende |
|---|---|---|
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Vorstandsvorsitzender | 22.04.2025 |
AbbVie AG
 AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dominik Höchli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
AbbVie AG
AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Commercial Services |
